Candida albicans Mutants Deficient in Respiration Are Resistant to the Small Cationic Salivary Antimicrobial Peptide Histatin 5
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Histatins are a group of small cationic peptides in human saliva which are well known for their antibacterial and antifungal activities. In a previous study we demonstrated that histatin 5 kills both blastoconidia and germ tubes of Candida albicans in a time- and concentration-dependent manner at 37°C, whereas no killing was detected at 4°C. This indicated that killing activity depends on cellular energy. To test histatin 5 killing activity at lower cellular ATP levels at 37°C, respiratory mutants, or so-called petite mutants, of C. albicans were prepared. These mutants are deficient in respiration due to mutations in mitochondrial DNA. Mutants were initially identified by their small colony size and were further characterized with respect to colony morphology, growth characteristics, respiratory activity, and cytochrome spectra. The killing activity of histatin 5 at the highest concentration was only 28 to 30% against respiratory mutants, whereas 98% of the wild-type cells were killed. Furthermore, histatin 5 killing activity was also tested on wild-type cells in the presence of the respiratory inhibitor sodium azide or, alternatively, the uncoupler carbonyl cyanide m-chlorophenylhydrazone. In both cases histatin 5 killing activity was significantly reduced. Additionally, supernatants and pellets of cells incubated with histatin 5 in the presence or absence of inhibitors of mitochondrial ATP synthesis were analyzed by sodium dodecyl sulfate gel electrophoresis. It was observed that wild-type cells accumulated large amounts of histatin 5, while wild-type cells treated with inhibitors or petite mutants did not accumulate significant amounts of the peptide. These data showed first that cellular accumulation of histatin 5 is necessary for killing activity and second that accumulation of histatin 5 depends on the availability of cellular energy. Therefore, mitochondrial ATP synthesis is required for effective killing activity of histatin 5.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a petite mutant from a histidine auxotroph of Candida albicans and its characterization
Roth-Ben Arie, Z., Altboum, Z., Berdicevsky, I., & Segal, E. (1998) · Mycopathologia · doi:10.1023/a:1006988119891 · Cited by 11
Cited by
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
Role of lipids in the interaction of antimicrobial peptides with membranes
Teixeira, V., Feio, M. J., & Bastos, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.12.005 · Cited by 692
Human Antimicrobial Peptides: Defensins, Cathelicidins and Histatins
De Smet, K., & Contreras, R. (2005) · Biotechnology Letters · doi:10.1007/s10529-005-0936-5 · Cited by 560
Human Antimicrobial Peptides and Proteins
Wang, G. (2014) · Pharmaceuticals · doi:10.3390/ph7050545 · Cited by 528
Ouhara, K., Komatsuzawa, H., Yamada, S., Shiba, H., Fujiwara, T., Ohara, M., Sayama, K., Hashimoto, K., Kurihara, H., & Sugai, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki103 · Cited by 428
Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars
Jin, Y., Samaranayake, L. P., Samaranayake, Y., & Yip, H. K. (2004) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2004.04.011 · Cited by 266
Sanglard, D., Ischer, F., & Bille, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1174-1183.2001 · Cited by 247
Histatins: Antimicrobial peptides with therapeutic potential
Kavanagh, K., & Dowd, S. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022971 · Cited by 223
Chen, Y., Montedonico, A. E., Kauffman, S., Dunlap, J. R., Menn, F., & Reynolds, T. B. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.07018.x · Cited by 144
“On these plates mutants lacking mitochondrial respiratory function take up the dye more readily than wild-type (Nagai, 1963; Gyurko et al., 2000).”
BackgroundMethodInfluentialT-2307 Causes Collapse of Mitochondrial Membrane Potential in Yeast
Shibata, T., Takahashi, T., Yamada, E., Kimura, A., Nishikawa, H., Hayakawa, H., Nomura, N., & Mitsuyama, J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05954-11 · Cited by 99
Relationships between Respiration and Susceptibility to Azole Antifungals in Candida glabrata
Brun, S., Aubry, C., Lima, O., Filmon, R., Bergès, T., Chabasse, D., & Bouchara, J.-P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.847-853.2003 · Cited by 64
Santos, R., Buisson, N., Knight, S. A. B., Dancis, A., Camadro, J., & Lesuisse, E. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04281.x · Cited by 55
“Some respiratory-deficient mutants of C. albicans have been described (Gyurko et al., 2000), but their growth on glucose was strongly decreased, unlike the petite mutants of S. cerevisiae.”
BackgroundRajkowska, K., Nowak, A., Kunicka-Styczyńska, A., & Siadura, A. (2016) · RSC Advances · doi:10.1039/c6ra21108a · Cited by 55
Geraghty, P., & Kavanagh, K. (2003) · Archives of Microbiology · doi:10.1007/s00203-003-0530-y · Cited by 45
Andrés, M. T., Acosta-Zaldívar, M., & Fierro, J. F. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03130-15 · Cited by 41
Novel mitochondrial complex I-inhibiting peptides restrain NADH dehydrogenase activity
Xue, Y.-P., Kao, M.-C., & Lan, C.-Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-50114-2 · Cited by 25
Metadata
- Authors
- Gyurko, C., Lendenmann, U., Troxler, R. F., & Oppenheim, F. G.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2000-02
- Volume
- 44
- Issue
- 2
- Pages
- 348-354
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2103805019
- Cited by
- 92
- References
- 1
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.